Concentrations of Phenylalanine and Tyrosine in Plasma and Brain of Rats Treated with Phenylalanine Loads K. N. ANTONAS and W. F. COULSON
The Middlesex Hospital Medical School, London WlP SPR, U.K. Antonas et al. (1974) reported that sustained treatment with p-chlorophenylalanine and phenylalanine over several days decreased the ability of weanling rats to cope with a phenylalanine load in such a way that, after 4 days pretreatment, such a load gave rise to hyperphenylalaninaemia lasting for several hours. It was also shown that during this period the concentration of tyrosine in plasma remained low, and hence the plasma phenylalanineltyrosine ratio resembled that found in phenylketonuria. The present communication describes experiments in which the concentrations of both phenylalanine and tyrosine in brain and plasmawere measured in control animals and animals pretreated with p-chlorophenylalanine, at various times after a phenylalanine load.
Weanling rats (about 20 days old) were divided into two groups. The treated group received 300mg of DL-p-chlorophenylalanine/kg plus 200mg of L-phenylalanine/kg each day, except on the day they were killed.
The control group were injected with equivalent volumes of 0.9 % NaCl except on the day they were killed.
After 1, 3 and 7 days of pretreatment, groups of three each of treated and control animals were killed, their blood was collected individually and their brains were removed and pooled. From each of the treated and control groups 15 animals were given a phenylalanine load of 500mg of L-phenylalanine/kg, and were killed in groups of three 560th MEETING, OXFORD at various times afterwards up to 3 h. The blood from each animal was collected and the brains of each group of three were pooled.
True plasma phenylalanine concentrations (i.e. determined after separation from p-chlorophenylalanine) and tyrosine concentrations were then determined as described by Antonas et al. (1974) .
The pooled brains were weighed and homogenized in 2vol. of ice-cold 1 M-HC~O~, centrifuged and the supernatant was used for the determination of phenylalanine and tyrosine by the above methods. The results are shown in Tables 1 and 2 .
The ability of the untreated controls to cope with a phenylalanine load increases with age, such that by 27 days of age the rise in plasma phenylalanine concentration is transient and small. However, the plasma concentrations do not reflect the situation in the brain, for in the 21-and 23-day-old animals the plasma concentration returns to normal after 1 h, but the concentration in the brain remains elevated for 3 h. At 27 days, however, the changes in the brain do reflect the plasma situation. The plasma tyrosine concentrations in the controls reach a peak later than those of phenylalanine (at 60min rather than Mmin), and reflect the increasing ability of the animals to cope with the phenylalanine load as they get older. In the brains of the control animals, the tyrosine concentrations throughout the period of the experiment are three times higher than in the non-loaded animals, even though the phenylalanine concentrations in the brains of the older animals show a return towards those present initially.
The treated animals show the cumulative effect of the daily treatment with p-chlorophenylalanine (Antonas etal., 1974). At 21 days (1 day of treatment), the plasma phenylalanine concentration, though elevated for longer than that of the controls, does return to normal within 3h. After 3 and 7 days of treatment, the plasma phenylalanine concentrations remain elevated for the whole 3 h period. The plasma tyrosine concentrations in the 3-and 7-day treatments show the effect of thep-chlorophenylalanine, being much less elevated than those of the controls. In these animals, the concentrations in the brain, in contrast with the controls, do reflect the plasma situation, showing a similar degree of elevation.
The results show that in the untreated animals of 23 days and older, a phenylalanine load produces only a very transient hyperphenylalaninaemia and that both the brain phenylalanine and tyrosine concentrations are elevated, so that any metabolic effects observed cannot be attributed to the phenylalanine alone. The animals pretreated for 3 or 7 days with p-chlorophenylalanine show markedly elevated plasma and brain phenylalanine concentrations for at least 3 h, and the phenylalanine/tyrosine ratio remains elevated for this period. However, in the 27-day-old animals the ratio is much lower in brain than in plasma, owing to the accumulation of tyrosine in the brain.
These very high concentrations of tyrosine in the brains of the untreated animals must arise from the hydroxylation of phenylalanine by liver phenylalanine hydroxylase, as it is widely acknowledged that the brain does not contain phenylalanine hydroxylase (Magee et al., 1972) , and although tyrosine hydroxylase hydroxylates phenylalanine in uifro (Shiman et al., 1971) , this conversion must be small in uiuo, as phenylketonurics show little ability to convert phenylalanine into tyrosine.
In conclusion, a phenylalanine load alone is inadequate for simulating phenylketonuria in rats because of the very high concentrations of tyrosine obtained. Pretreatment of the animals for several days withp-chlorophenylalanine in rats of less than 23 days old produces acceptably high concentrations of phenylalanine in plasma and brain with concomitantly low tyrosine concentrations.
In such experiments it is necessary to measure both brain and plasma amino acid concentrations, as there is not a constant relationship between these parameters. Vol. 4
